Bluefin Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,800
| Closed | -$1.24M | – | 123 |
|
|
2025
Q4 | $1.24M | Buy |
+3,800
| New | +$1.21M | 0.31% | 46 |
|
|
2022
Q1 | – | Sell |
-5,500
| Closed | -$1.24M | – | 671 |
|
|
2021
Q4 | $1.24M | Buy |
+5,500
| New | +$1.16M | 0.09% | 179 |
|
|
2021
Q1 | – | Sell |
-3,544
| Closed | -$815K | – | 777 |
|
|
2020
Q4 | $815K | Buy |
+3,544
| New | +$817K | 0.05% | 212 |
|
|
2020
Q3 | – | Sell |
-1,140
| Closed | -$269K | – | 483 |
|
|
2020
Q2 | $269K | Buy |
1,140
+90
| +9% | +$20.5K | 0.02% | 203 |
|
|
2020
Q1 | $213K | Sell |
1,050
-14,702
| -93% | -$3.21M | 0.03% | 248 |
|
|
2019
Q4 | $3.8M | Buy |
15,752
+9,262
| +143% | +$2.04M | 0.25% | 97 |
|
|
2019
Q3 | $1.26M | Buy |
+6,490
| New | +$1.25M | 0.18% | 94 |
|
|
2019
Q2 | – | Sell |
-1,239
| Closed | -$222K | – | 333 |
|
|
2019
Q1 | $235K | Buy |
+1,239
| New | +$237K | 0.03% | 199 |
|
|
2018
Q4 | – | Sell |
-5,356
| Closed | -$1.11M | – | 418 |
|
|
2018
Q3 | $1.11M | Buy |
+5,356
| New | +$1.06M | 0.1% | 157 |
|
|
2017
Q4 | – | Sell |
-1,647
| Closed | -$307K | – | 482 |
|
|
2017
Q3 | $307K | Sell |
1,647
-204
| -11% | -$36.1K | 0.04% | 263 |
|
|
2017
Q2 | $319K | Sell |
1,851
-2,008
| -52% | -$327K | 0.03% | 275 |
|
|
2017
Q1 | $633K | Buy |
3,859
+1,941
| +101% | +$323K | 0.08% | 165 |
|
|
2016
Q4 | $280K | Sell |
1,918
-2,706
| -59% | -$407K | 0.02% | 286 |
|
|
2016
Q3 | $771K | Buy |
4,624
+443
| +11% | +$74.9K | 0.03% | 151 |
|
|
2016
Q2 | $636K | Buy |
+4,181
| New | +$650K | 0.06% | 185 |
|
|
2016
Q1 | – | Sell |
-4,499
| Closed | -$730K | – | 469 |
|
|
2015
Q4 | $730K | Sell |
4,499
-3,160
| -41% | -$497K | 0.06% | 265 |
|
|
2015
Q3 | $1.06M | Buy |
7,659
+5,915
| +339% | +$932K | 0.06% | 185 |
|
|
2015
Q2 | $268K | Buy |
+1,744
| New | +$279K | 0.02% | 379 |
|
|
2015
Q1 | – | Sell |
-25,331
| Closed | -$4.04M | – | 416 |
|
|
2014
Q4 | $4.04M | Buy |
25,331
+23,840
| +1,599% | +$3.71M | 0.24% | 92 |
|
|
2014
Q3 | $209K | Buy |
+1,491
| New | +$195K | 0.01% | 579 |
|
|
2014
Q2 | – | Sell |
-4,225
| Closed | -$500K | – | 702 |
|
|
2014
Q1 | $500K | Buy |
+4,225
| New | +$512K | 0.03% | 312 |
|
|
2013
Q3 | – | Sell |
-3,210
| Closed | -$300K | – | 417 |
|
|
2013
Q2 | $300K | Buy |
+3,210
| New | +$333K | 0.03% | 371 |
|
Other funds holding AMGN
VCM
VPM
Bluefin Capital Management's AMGN Position: Q1 2026 in Review
Bluefin Capital Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 3,800 shares — an estimated $1.24M sold.
Bluefin Capital Management first reported a position in AMGN in Q2 2013 and held it in 22 quarters. The position peaked at $4.04M in Q4 2014. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Bluefin Capital Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Bluefin Capital Management sold 3,800 Amgen shares in Q1 2026, an estimated $1.24M.
- Bluefin Capital Management first reported a position in Amgen in Q2 2013 and held it in 22 quarters.
- Bluefin Capital Management's Amgen position peaked at $4.04M in Q4 2014.
- 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.